Yan J, Mehta S, Patel K, Dhupar N, Little N, Ong Tone S
Sci Rep. 2024; 14(1):10276.
PMID: 38704483
PMC: 11069521.
DOI: 10.1038/s41598-024-61170-8.
Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A
BioTech (Basel). 2023; 12(2).
PMID: 37366796
PMC: 10295950.
DOI: 10.3390/biotech12020048.
Wong Y, Liu S, Walkden A
Clin Ophthalmol. 2022; 16:647-659.
PMID: 35282168
PMC: 8904263.
DOI: 10.2147/OPTH.S349582.
Rocha-de-Lossada C, Rachwani-Anil R, Borroni D, Sanchez-Gonzalez J, Esteves-Marques R, Soler-Ferrandez F
J Ophthalmol. 2021; 2021:6644114.
PMID: 34306743
PMC: 8285186.
DOI: 10.1155/2021/6644114.
Yuan A, Pineda R
Taiwan J Ophthalmol. 2021; 11(2):122-131.
PMID: 34295617
PMC: 8259529.
DOI: 10.4103/tjo.tjo_23_20.
Update on the Surgical Management of Fuchs Endothelial Corneal Dystrophy.
Blitzer A, Colby K
Ophthalmol Ther. 2020; 9(4):757-765.
PMID: 32840804
PMC: 7708572.
DOI: 10.1007/s40123-020-00293-3.
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.
Ong Tone S, Kocaba V, Bohm M, Wylegala A, White T, Jurkunas U
Prog Retin Eye Res. 2020; 80:100863.
PMID: 32438095
PMC: 7648733.
DOI: 10.1016/j.preteyeres.2020.100863.
The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants.
Zhang J, Patel D, McGhee C
Asia Pac J Ophthalmol (Phila). 2019; 8(6):441-447.
PMID: 31789646
PMC: 6903320.
DOI: 10.1097/APO.0000000000000265.
Corneal clearance and central endothelial cell repopulation despite graft detachment after Descemet membrane endothelial keratoplasty.
Daravagka M, Nestler A, Wiedemann P, Girbardt C
GMS Ophthalmol Cases. 2019; 9:Doc14.
PMID: 31157156
PMC: 6533462.
DOI: 10.3205/oc000103.
Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy.
Okumura N, Hayashi R, Koizumi N
Open Ophthalmol J. 2018; 12:154-163.
PMID: 30123380
PMC: 6062905.
DOI: 10.2174/1874364101812010154.
A Historical Perspective on Treatment of Fuchs' Endothelial Dystrophy: We have Come a Long Way.
Moshirfar M, Ding Y, J Shah T
J Ophthalmic Vis Res. 2018; 13(3):339-343.
PMID: 30090191
PMC: 6058545.
DOI: 10.4103/jovr.jovr_94_18.
Association of the Gutta-Induced Microenvironment With Corneal Endothelial Cell Behavior and Demise in Fuchs Endothelial Corneal Dystrophy.
Kocaba V, Katikireddy K, Gipson I, Price M, Price F, Jurkunas U
JAMA Ophthalmol. 2018; 136(8):886-892.
PMID: 29852040
PMC: 6142944.
DOI: 10.1001/jamaophthalmol.2018.2031.
Mini descemet membrane stripping (m-DMES) in patients with Fuchs' endothelial dystrophy: A new method.
Kymionis G, Liakopoulos D, Grentzelos M, Naoumidi I, Kontadakis G, Tsoulnaras K
Saudi J Ophthalmol. 2017; 31(4):275-279.
PMID: 29234234
PMC: 5717510.
DOI: 10.1016/j.sjopt.2017.05.010.
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases.
Okumura N, Kinoshita S, Koizumi N
J Ophthalmol. 2017; 2017:2646904.
PMID: 28751979
PMC: 5511675.
DOI: 10.1155/2017/2646904.
[Descemetectomy : An alternative to transplantation?].
Bramann E, Schroder K, Schrader S, Geerling G
Ophthalmologe. 2017; 114(7):666-669.
PMID: 28597204
DOI: 10.1007/s00347-017-0516-9.
[Corneal cell therapy-an overview].
Fuest M, Yam G, Peh G, Walter P, Plange N, Mehta J
Ophthalmologe. 2017; 114(8):705-715.
PMID: 28204869
DOI: 10.1007/s00347-017-0454-6.
What does the future hold for the treatment of Fuchs endothelial dystrophy; will 'keratoplasty' still be a valid procedure?.
Bruinsma M, Tong C, Melles G
Eye (Lond). 2013; 27(10):1115-22.
PMID: 23846374
PMC: 3806561.
DOI: 10.1038/eye.2013.153.
